This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| European Surveillance of Veterinary Antimicrobial Consumption | |
|---|---|
| Name | European Surveillance of Veterinary Antimicrobial Consumption |
| Abbreviation | ESVAC |
| Established | 2010 |
| Jurisdiction | European Union |
| Parent organization | European Medicines Agency, European Commission |
European Surveillance of Veterinary Antimicrobial Consumption The European Surveillance of Veterinary Antimicrobial Consumption program monitors veterinary antimicrobial use across European Union member states, supporting efforts to combat antimicrobial resistance linked to animal health and food safety. It compiles quantitative data to inform policy debates involving institutions such as the European Medicines Agency, the European Commission, the European Parliament, and national competent authorities like the Agence nationale de sécurité du médicament et des produits de santé and the Medicines and Healthcare products Regulatory Agency. The initiative interacts with international actors including the World Health Organization, the Food and Agriculture Organization of the United Nations, and the World Organisation for Animal Health.
ESVAC aims to collect harmonized data on sales and use of veterinary antimicrobials to guide risk assessment and policy by bodies such as the European Food Safety Authority, the Council of the European Union, and the European Centre for Disease Prevention and Control. Objectives include informing regulatory instruments like the Regulation (EU) 2019/6 on veterinary medicinal products and influencing strategies crafted by the European Green Deal, the Farm to Fork Strategy, and the One Health initiatives promoted by the G7 and G20. Outputs support stakeholders including national ministries (for example, Ministry of Agriculture (France), Royal Dutch Ministry of Agriculture, Nature and Food Quality), producer organizations like the European Livestock and Meat Trades Union, and research institutions such as Wageningen University and the University of Copenhagen.
ESVAC was launched within the European Medicines Agency framework following policy momentum generated by the Codex Alimentarius Commission debates and sentinel reports from institutions like the European Commission Directorate-General for Health and Food Safety and national surveillance systems including Denmark’s DANMAP and the Swedish Veterinary Antibiotic Use Surveillance program. The program evolved alongside major policy milestones such as the Ban on antibiotic growth promoters in the European Union and the development of action plans by the World Health Assembly and the European Commission’s 2011 Action Plan against the rising threats from Antimicrobial Resistance. Collaboration expanded to research networks including ECDC-linked studies and projects funded under the Horizon 2020 framework.
ESVAC compiles sales and usage data reported by national competent authorities, pharmaceutical marketing authorization holders, wholesalers, and veterinary practitioners, aligning with coding systems such as the Anatomical Therapeutic Chemical Classification System adapted for veterinary use and metrics like milligrams of active substance per kilogram of biomass. Data pipelines draw on national databases like VetStat (Denmark), Reseptregisteret (Norway), and industry datasets from groups such as the European Federation of Pharmaceutical Industries and Associations and the International Federation for Animal Health. Analytic methods reference guidance from the European Surveillance of Antimicrobial Consumption Network and statistical standards employed by the European Statistical System, with cross-validation against studies from Imperial College London, University of Oxford, and the Johns Hopkins Bloomberg School of Public Health.
Governance involves the European Medicines Agency’s coordination unit, technical working groups with representatives from member states, and stakeholders including the European Commission Directorate-General for Health and Food Safety, veterinary associations such as the Federation of Veterinarians of Europe, and scientific advisory groups linked to the European Food Safety Authority. Participating national authorities include agencies like the Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail, the Federal Office of Public Health (Switzerland), and the Bundesinstitut für Arzneimittel und Medizinprodukte. International partners include the World Organisation for Animal Health and the Food and Agriculture Organization of the United Nations.
ESVAC reports have documented declining overall sales of veterinary antimicrobials in several EU Member States, contrasting with persistent use of critical antimicrobials such as third- and fourth-generation cephalosporins and fluoroquinolones highlighted by surveillance from European Centre for Disease Prevention and Control and research from institutions like Karolinska Institutet and Inserm. Geographic patterns echo findings from national systems including DANMAP and Anses reports, with species-specific differences noted in poultry, swine, and bovine sectors studied at universities like Ghent University and Universidade de Lisboa. Analyses inform risk assessments by the European Food Safety Authority and case studies published by journals linked to Nature Research and The Lancet family.
ESVAC data have influenced regulatory measures such as provisions in Regulation (EU) 2019/6, revisions of marketing authorization practices coordinated with the European Commission, and stewardship guidelines promoted by the World Health Organization and the Food and Agriculture Organization of the United Nations. National responses include targeted reduction campaigns in countries like the Netherlands and Denmark, incentivized stewardship in schemes modeled after Sweden’s veterinary policies, and research funding through programs like Horizon Europe. Parliamentary debates in bodies such as the European Parliament and ministerial decisions within the Council of the European Union have cited ESVAC evidence in adopting surveillance and restraint measures.
Challenges include harmonizing heterogeneous data systems across member states, addressing off-label and cascade use overseen by national veterinary regulators like the Veterinary Medicines Directorate (UK), and integrating farm-level usage data comparable to public health surveillance frameworks exemplified by the European Surveillance System (TESSy). Future directions emphasize linking ESVAC outputs to outcome measures on antimicrobial resistance monitored by the European Antimicrobial Resistance Surveillance Network, enhancing interoperability with databases managed by Eurostat and promoting One Health research collaborations with institutions such as Harvard T.H. Chan School of Public Health, University of Cambridge, and ETH Zurich. Continued policy engagement is expected with the European Commission and global forums including the United Nations General Assembly and the G20.
Category:Veterinary medicine